StockNews.com has added Galectin Therapeutics (NASDAQ:GALT) to its coverage list.
The findings of the Galectin Therapeutics research carried out by StockNews.com and made public on Thursday were incorporated into the ...
Tag: GALT, Analyst Rating
HC Wainwright Reaffirms Galectin Therapeutics (NASDAQ:GALT) Stock Rating
In a research note distributed to investors on Friday, analysts from HC Wainwright reaffirmed their "buy" rating on shares of ...
Analysts at StockNews.com have added new coverage to Galectin Therapeutics (NASDAQ:GALT).
Galectin Therapeutics was the topic of a research report distributed to clients and investors by StockNews.com analysts for the very ...